Search clinical trials for: paroxetine immediate release (IR)

Total 13375 results

University Hospital, Strasbourg, France

Not yet recruiting

Efficiency of a Telemedicine-based Follow-up on for the Medical Management of Patients Leaving the Intensive Care Unit (TéléRéa)

Care After Going to Intensive Care

France
Queen Mary University of London
University College, London

Withdrawn

The Effects of C-type Natriuretic Peptide on Human Forearm Blood Vessels

Ischaemia-reperfusion (IR) Injury

United Kingdom
IR Technology, LLC

Completed

Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss

Obesity | Body Weight | Cellulite | Fat Burn | Abdominal Fat | Adipose Tissue Atrophy

United States
Janssen Research & Development, LLC

Completed

Effect of Food on a Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release in Healthy Volunteers

Healthy
Biocodex

Recruiting

Effect of Ultra-gyn® on Vulvovaginal Candidiasis

Vulvovaginal Candidiasis, Genital

Mauritius
The Hospital for Sick Children

Completed

Clinical and Genomic Responses to Open Heart Surgery

Ischemia-reperfusion (IR) Injury

Canada
IR Technology, LLC

Not yet recruiting

Clinical Trial of the invisaRED® IR REHAB Device When Used as an Adjunctive Therapy for Nociceptive Musculoskeletal Pain

Musculoskeletal Pain | Nociceptive Pain
Stallergenes Greer

Completed

Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite (HDM) Tablets in Allergic Rhinitis Environment Exposure Chamber Model

House Dust Mites Allergic Rhinitis

Canada
IR Scientific Inc.

Completed

Efficacy of Sensi-IP Toothpaste in the Treatment of Dentinal Hypersensitivity Compared to a Sodium Fluoride Toothpaste

Dentinal Hypersensitivity

United States
Bioxodes S.A.

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ir-CPI in Healthy Male Subjects

Healthy

Belgium
Cerevel Therapeutics, LLC

Recruiting

A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants

Healthy Participants

United States
Pfizer

Completed

A Sub Study to Evaluate the Study Medication (Etrasimod) Using Wearable Sensors in Healthy Participants

Healthy Participants

Belgium
ANRS, Emerging Infectious Diseases
University Hospital, Bordeaux; Saint-Louis Hospital, Paris, France; Bichat Hospital and other collaborators

Recruiting

Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo. (DepIST-H)

HIV Infections | Papillomavirus Infections

Togo
Bayer

Completed

A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight

Renal Impairment | Chronic Kidney Disease | Healthy Volunteers

Germany
Incyte Corporation

Active, not recruiting

A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.

Healthy Participants

United States
Institut Pasteur de Lille
Luxomed

Terminated

Interest in the Medium Term of an Infrared Reflexotherapy on Overweight or Class I Obese People (REFLEX-IR)

Assess the Effect of an IR Reflexotherapy on Overweight and Class I Obese People

France
F2G Biotech GmbH
Quotient Clinical

Completed

Evaluation of Immediate Release Tablet

Invasive Aspergillosis

United Kingdom
Bellus Health Inc. - a GSK company

Recruiting

Assessment of the Pharmacokinetics of BLU-5937 Extended Release Prototypes and a BLU-5937 Immediate Release Reference Formulation

Healthy | Cough

United Kingdom
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin IR Tablets (2 x 850 mg) in Healthy Volunteers

Healthy

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

Healthy

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR)

Substance Abuse Detection
Agence de Médecine Préventive, France
Pfizer; Centre Muraz; Region Sanitaire des Savanes, Togo; Ministere de la Sante... and other collaborators

Unknown

Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013

Pneumonia, Viral | Pneumonia, Bacterial | Meningitis, Bacterial

Togo
Benha University

Completed

Fatty Liver Among Employees at Banha University (fattyliver)

Fatty Liver Disease | Fatty Infiltration

Egypt
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers

Healthy

United States
Bristol-Myers Squibb

Completed

A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants

Healthy Volunteers

United States
Integrate Health
Albert Einstein College of Medicine; Montefiore Medical Center; City University... and other collaborators

Unknown

Integrated Community Based Health Systems Strengthening Preliminary Study in Kozah Togo (ICBHSS-Kozah)

Maternal-Child Health Services | Health Service Utilization

Togo
Integrate Health
Albert Einstein College of Medicine; Montefiore Medical Center; City University... and other collaborators

Unknown

Integrated Community Based Health Systems Strengthening in Northern Togo (ICBHSS-Togo)

Maternal and Child Health | Health Service Utilization

Togo
Ectosense NV
Ziekenhuis Oost-Limburg

Unknown

Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test

Sleep Apnea

Belgium
Impax Laboratories, LLC

Completed

Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease

Parkinson's Disease

United States
Ectosense NV
Ziekenhuis Oost-Limburg

Unknown

Extensive Prospective Validation Study of the NightOwl Home Sleep Apnea Test

Sleep Apnea

Belgium
Merck KGaA, Darmstadt, Germany

Completed

Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes (CONSENT)

Diabetes Mellitus, Type 2

Germany
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Melanoma | Small Cell Lung Cancer | Colorectal Neoplasms | Ovarian Neoplasms | Liposarcoma

United States
MetroHealth Medical Center

Completed

SIC-IR Billing and Documentation (SIC-IR)

Medical Record Documenation | Surgical and Trauma Intensive Care Unit Billing

United States
Stallergenes Greer

Completed

Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

Rhinitis, Allergic, Perennial | House Dust Mite Allergy

France, United States
Rutgers, The State University of New Jersey

Not yet recruiting

Developing and Testing a Nurse-Led Technology-Enhanced Family Engagement Program

Critical Illness

United States
Rutgers, The State University of New Jersey

Completed

Family Presence on Multidisciplinary Patient Care Rounds in ICU

Critical Illness

United States
Landos Biopharma Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Ulcerative Colitis

United States, Ukraine
GlaxoSmithKline

Completed

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
University of North Carolina, Chapel Hill
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Evaluation of Child Care Staff Weight Management Program

Obesity

United States
GlaxoSmithKline

Completed

A Local Register Study For Major Depression Of Paroxetine Controlled Release

Depressive Disorder, Major | Major Depressive Disorder (MDD)

China
GlaxoSmithKline

Completed

Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib

Cancer

Australia
Diakonessenhuis, Utrecht

Recruiting

Secondary Obliteration of Old Radical Cavities Using S53P4 Bioactive Glass

Mastoid Cavity

Netherlands
Alexion

Recruiting

A Study to Investigate the Pharmacokinetic Profile of ALXN2050 Modified Release Prototype Formulations and Immediate Release Reference Tablet in Healthy Adult Participants

Healthy Participants

United Kingdom
MapLight Therapeutics

Enrolling by invitation

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

Autism Spectrum Disorder

United States, Australia
Bristol-Myers Squibb

Completed

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors

Neoplasms | Solid Tumors | Metastases

Australia
Janssen Research & Development, LLC

Completed

A Study of Tapentadol Immediate-Release in the Treatment of Patients With Acute Pain From Bunionectomy

Hallux Valgus

Korea, Republic of
Assiut University

Not yet recruiting

Prevalence of IR in Overweight and Obese Adolescents (IR)

Insulin Resistance
Bioxodes S.A.

Recruiting

A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage (BIRCH)

Intracerebral Hemorrhage

Belgium
Pfizer

Completed

Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers

Rheumatoid Arthritis

United States
Memorial Sloan Kettering Cancer Center

Completed

Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis

Metastatic or Recurrent Lesions in the Spine | Metastatic or Recurrent Lesions in the Pelvis

United States

3

Subscribe